Status | Study |
Active, not recruiting |
Study Name: Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Condition: Adult Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Date: 2012-01-27 Interventions: Drug: Azacitidine Given SC or |
Terminated |
Study Name: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler Condition: Acute Myeloid Leukemia (AML) Acute Promyelocytic Leukemia (APL) Date: 2011-10-28 |
Completed |
Study Name: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies Condition: Acute Lymphoid Leukemia Acute Myeloid Leukemia Date: 2011-10-24 Interventions: Drug: brentuximab vedotin 1.8 |
Recruiting |
Study Name: Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Date: 2011-02-15 Interventions: Procedure: Allogeneic Bone Marrow Transplantation |
Completed |
Study Name: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission Date: 2010-08-03 Interventions: Procedure: umbilical cord blood transplantation |
Completed |
Study Name: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome Condition: Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Date: 2010-07-14 Interventions: Other: flow cytometry Correlat |
Completed |
Study Name: Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Date: 2010-06-16 Interventions: Other: laboratory biomarker analysis Correlative studies |
Withdrawn |
Study Name: T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies Condition: Hematologic Malignancy Acute Myeloid Leukemia Acute Lympho Date: 2010-05-26 Interventions: Biological: Treg cells Given b |
Active, not recruiting |
Study Name: Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm Condition: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia Wit Date: 2010-04-08 Interventions: Biological: filgrastim Given S |
Withdrawn |
Study Name: Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant Condition: AML ALL Undifferentiated Leukemia Date: 2009-11-11 Interventions: Drug: Abatacept Participants will receive one of two standard myeloablative conditioning regimens for th |